Sigma Pharmaceuticals Limited - Premium Company Report Australia

31-01-2012, 17 pages

Sigma Pharmaceuticals Limited is a Public Company that is ranked number 116 out of the top 2000 companies in Australia. The company generates the majority of its income from the Pharmaceutical Product Manufacturing in Australia industry.

In 2012 the company generated total revenue of $2,897,627,000 including sales and other revenue. The exact number of employees for this organisation is not available.

The Chief Executive of Sigma Pharmaceuticals Limited is Mr Mark Hooper whose official title is Managing Director. The Chairman of Sigma Pharmaceuticals Limited is Mr Brian Jamieson whose official title is Non-Executive Chairman.

The company is engaged in the wholesale distribution and retail of pharmaceutical products through its Healthcare operations.

The wholesale division provides wholesale and distribution service to independent and banner membership pharmacies. Operational functions include buying and merchandising, logistics, warehousing, and sales.

The retail division is responsible for providing advertising, marketing, training and private label products to its brand pharmacies, Amcal, Guardian and AmcalMax.

IBISWorld Premium Company Reports

The IBISWorld Company Premium Report offers a wealth of information on the top 550 companies. The detailed information and analysis in the Premium Report help you become better informed on all company activities. IBISWorld Company Premium Reports include: